1, 9-Pyrazoloanthrones Downregulate HIF-1α and Sensitize Cancer Cells to Cetuximab-Mediated Anti-EGFR Therapy

Cetuximab, a monoclonal antibody that blocks the epidermal growth factor receptor (EGFR), is currently approved for the treatment of several types of solid tumors. We previously showed that cetuximab can inhibit hypoxia-inducible factor-1 alpha (HIF-1α) protein synthesis by inhibiting the activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yang, Li, Xinqun, Lu, Haiquan, Fan, Zhen
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012113/
https://www.ncbi.nlm.nih.gov/pubmed/21209911
http://dx.doi.org/10.1371/journal.pone.0015823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012113/
https://www.ncbi.nlm.nih.gov/pubmed/21209911
http://dx.doi.org/10.1371/journal.pone.0015823

Ejemplares similares